Eli Lilly (LLY)

• Market cap: $922B
• 1 day: -0.31%
• 5 days: -6.05%
• 1 month: 13.62%
• 3 months: 38.69%
• 6 months: 34.54%
• Year to date: 32.43%
• 1 year: 24.16%
• 5 years: 594.08%
• 10 years: 1,089.52%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Employees: 47,000